Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

COVID-19

Free Subscription Articles published in Lancet Retrieve available abstracts of 432 articles: HTML format

Single Articles

July 2026
1. CRIVELLI L, Suemoto CK, Sosa AL, Lopera F, et al
   Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.
   Lancet. 2026 Jul 13:S0140-6736(26)01278-X. doi: 10.1016/S0140-6736(26)01278.
   PubMed     Abstract available
   
   
   
2. DEZZA FC, Pulido LB, Borreguero IB, Perez FD, et al
   Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTE): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.
   Lancet. 2026 Jul 9:S0140-6736(26)00760-9. doi: 10.1016/S0140-6736(26)00760.
   PubMed     Abstract available
   
   
   June 2026
3. BLAKNEY AK, Top KA, Cowling BJ, Larson HJ, et al
   Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.
   Lancet. 2026 Jun 30:S0140-6736(26)00512-X. doi: 10.1016/S0140-6736(26)00512.
   PubMed     Abstract available
   
   
   
4. ABUBAKAR I, Tellez D, Aldridge RW, Altare C, et al
   The UCL-Lancet Commission on Migration and Health: review of the state of progress.
   Lancet. 2026;407:2554-2576.
   PubMed     Abstract available
   
   
   
5. SASIENI P, Falcaro M
   Cervical cancer mortality trends following HPV vaccination in England, 2001-24: an analysis of population-based mortality data.
   Lancet. 2026 Jun 17:S0140-6736(26)00918-9. doi: 10.1016/S0140-6736(26)00918.
   PubMed     Abstract available
   
   
   
6. 
   Benzylpenicillin versus flucloxacillin or cloxacillin for the treatment of penicillin-susceptible Staphylococcus aureus bacteraemia (SNAP): an international, multicentre, open-label, non-inferiority randomised controlled trial.
   Lancet. 2026 Jun 17:S0140-6736(26)00761-0. doi: 10.1016/S0140-6736(26)00761.
   PubMed     Abstract available
   
   
   
7. KARIM SA, Mahomed S, Lewis L, Karim SSA, et al
   Urgent need for a reliable rapid diagnostic test for the Ebola epidemic caused by Bundibugyo virus in Africa.
   Lancet. 2026 Jun 2:S0140-6736(26)01093-7. doi: 10.1016/S0140-6736(26)01093.
   PubMed    
   
   
   May 2026
8. GIOVANNONI G, Airas L, Bove R, Cutter GR, et al
   Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study.
   Lancet. 2026;407:2195-2207.
   PubMed     Abstract available
   
   
   
9. ISLAM MS, Chughtai AA, Wood JG, Sawleshwarkar S, et al
   Hantavirus outbreak on a cruise ship in the South Atlantic.
   Lancet. 2026 May 15:S0140-6736(26)00934-7. doi: 10.1016/S0140-6736(26)00934.
   PubMed    
   
   
   April 2026
10. SHANKAR-HARI M, Ming D, Mendelson M, Rupali P, et al
    The Lancet Commission on Sepsis: transforming sepsis care and outcomes.
    Lancet. 2026 Apr 22:S0140-6736(26)00648-3. doi: 10.1016/S0140-6736(26)00648.
    PubMed    
    
    
    February 2026
11. NYBERG ST, Frank P, Ahmadi-Abhari S, Pentti J, et al
    Adult obesity and risk of severe infections: a multicohort study with global burden estimates.
    Lancet. 2026 Feb 9:S0140-6736(25)02474-2. doi: 10.1016/S0140-6736(25)02474.
    PubMed     Abstract available
    
    
    January 2026
12. PETO J
    The UK COVID-19 Inquiry and the next pandemic.
    Lancet. 2026;407:220-221.
    PubMed    
    
    
    
13. WHITAKER M, Elliott J, Gerard-Ursin I, Cooke GS, et al
    Profiling vaccine attitudes and subsequent uptake in 1.1 million people in England: a nationwide cohort study.
    Lancet. 2026 Jan 12:S0140-6736(25)01912-9. doi: 10.1016/S0140-6736(25)01912.
    PubMed     Abstract available
    
    
    December 2025
14. 
    Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2025;404:2543-2583.
    PubMed     Abstract available
    
    
    
15. RUTTER H, Wabnitz K, Nambiar D, Garde A, et al
    The Lancet Commission on improving population health post-COVID-19.
    Lancet. 2025 Dec 11:S0140-6736(25)02061-6. doi: 10.1016/S0140-6736(25)02061.
    PubMed    
    
    
    November 2025
16. ZIEGLER AG, Achenbach P, Weiss A, Berner R, et al
    Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial.
    Lancet. 2025 Nov 11:S0140-6736(25)01726-X. doi: 10.1016/S0140-6736(25)01726.
    PubMed     Abstract available
    
    
    
17. MAYER KH, Beyrer C, Cohen MS, El-Sadr WM, et al
    Challenges and opportunities in developing integrated sexual and reproductive health programmes.
    Lancet. 2025;406:2168-2190.
    PubMed     Abstract available
    
    
    October 2025
18. SEDKY J, Gardner A, Ivers LC
    Loans dominated COVID-19 funding: it's time to adjust.
    Lancet. 2025;406:1946.
    PubMed    
    
    
    
19. THE LANCET
    Health progress in a post-COVID-19 world.
    Lancet. 2025 Oct 12:S0140-6736(25)01947-6. doi: 10.1016/S0140-6736(25)01947.
    PubMed    
    
    
    
20. 
    Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
    Lancet. 2025 Oct 12:S0140-6736(25)01917-8. doi: 10.1016/S0140-6736(25)01917.
    PubMed     Abstract available
    
    
    
21. 
    Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023.
    Lancet. 2025 Oct 12:S0140-6736(25)01330-3. doi: 10.1016/S0140-6736(25)01330.
    PubMed     Abstract available
    
    
    
22. 
    Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Stud
    Lancet. 2025 Oct 12:S0140-6736(25)01637-X. doi: 10.1016/S0140-6736(25)01637.
    PubMed     Abstract available
    
    
    
23. NDEMBI N, Mercy K, Folayan MO, Abdool Karim SS, et al
    Analysis of mpox in Angola conflates distinct timelines.
    Lancet. 2025;406:e29.
    PubMed    
    
    
    
24. REHM J, Assanangkornchai S, Hendershot CS, Franklin A, et al
    Alcohol use disorders.
    Lancet. 2025 Oct 9:S0140-6736(25)01496-5. doi: 10.1016/S0140-6736(25)01496.
    PubMed     Abstract available
    
    
    
25. RANDERATH W, Grote L, Stenlof K, Fietze I, et al
    Sultiame once per day in obstructive sleep apnoea (FLOW): a multicentre, randomised, double-blind, placebo-controlled, dose-finding, phase 2 trial.
    Lancet. 2025 Oct 9:S0140-6736(25)01196-1. doi: 10.1016/S0140-6736(25)01196.
    PubMed     Abstract available
    
    
    September 2025
26. FRISONI GB, Hansson O, Nichols E, Garibotto V, et al
    New landscape of the diagnosis of Alzheimer's disease.
    Lancet. 2025;406:1389-1407.
    PubMed     Abstract available
    
    
    
27. 
    The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023.
    Lancet. 2025 Sep 24:S0140-6736(25)01635-6. doi: 10.1016/S0140-6736(25)01635.
    PubMed     Abstract available
    
    
    August 2025
28. CHANG AY, Bolongaita S, Cao B, Castro MC, et al
    Epidemiological and demographic trends and projections in global health from 1970 to 2050: a descriptive analysis from the third Lancet Commission on Investing in Health, Global Health 2050.
    Lancet. 2025;406:940-949.
    PubMed     Abstract available
    
    
    July 2025
29. 
    Global HIV targets: a roadmap to 2030 and beyond.
    Lancet. 2025 Jul 16:S0140-6736(25)01449-7. doi: 10.1016/S0140-6736(25)01449.
    PubMed    
    
    
    
30. NEPOGODIEV D, Picciochi M, Ademuyiwa A, Adisa A, et al
    Surgical health policy 2025-35: strengthening essential services for tomorrow's needs.
    Lancet. 2025 Jul 14:S0140-6736(25)00985-7. doi: 10.1016/S0140-6736(25)00985.
    PubMed     Abstract available
    
    
    
31. WINKLER AS, Brux CM, Carabin H, das Neves CG, et al
    The Lancet One Health Commission: harnessing our interconnectedness for equitable, sustainable, and healthy socioecological systems.
    Lancet. 2025 Jul 14:S0140-6736(25)00627-0. doi: 10.1016/S0140-6736(25)00627.
    PubMed    
    
    
    
32. APEAGYEI AE, Bisignano C, Elliott H, Hay SI, et al
    Tracking development assistance for health, 1990-2030: historical trends, recent cuts, and outlook.
    Lancet. 2025 Jul 14:S0140-6736(25)01240-1. doi: 10.1016/S0140-6736(25)01240.
    PubMed     Abstract available
    
    
    June 2025
33. 
    Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023.
    Lancet. 2025 Jun 24:S0140-6736(25)01037-2. doi: 10.1016/S0140-6736(25)01037.
    PubMed     Abstract available
    
    
    
34. PAIL O, Lin MJ, Anagnostou T, Brown BD, et al
    Cancer vaccines and the future of immunotherapy.
    Lancet. 2025 Jun 17:S0140-6736(25)00553-7. doi: 10.1016/S0140-6736(25)00553.
    PubMed     Abstract available
    
    
    May 2025
35. KAZATCHKINE M, Liden J
    Seeking an inclusive and just way to simplify the global health architecture.
    Lancet. 2025 May 29:S0140-6736(25)01100-6. doi: 10.1016/S0140-6736(25)01100.
    PubMed    
    
    
    April 2025
36. AMOUZOU A, Barros AJD, Requejo J, Faye C, et al
    The 2025 report of the Lancet Countdown to 2030 for women's, children's, and adolescents' health: tracking progress on health and nutrition.
    Lancet. 2025 Apr 9:S0140-6736(25)00151-5. doi: 10.1016/S0140-6736(25)00151.
    PubMed    
    
    
    
37. SUN L, Selbie D, Khan AS, Karim SSA, et al
    Mobilising national and regional assets and non-state actors for pandemic preparedness.
    Lancet. 2025 Apr 3:S0140-6736(25)00630-0. doi: 10.1016/S0140-6736(25)00630.
    PubMed    
    
    
    
38. YUNAS I, Islam MA, Sindhu KN, Devall AJ, et al
    Causes of and risk factors for postpartum haemorrhage: a systematic review and meta-analysis.
    Lancet. 2025 Apr 3:S0140-6736(25)00448-9. doi: 10.1016/S0140-6736(25)00448.
    PubMed     Abstract available
    
    
    March 2025
39. GOSTIN LO, Friedman EA, Dhai A, Zia-Zarifi S, et al
    COVID-19: border closures violate human rights - Authors' reply.
    Lancet. 2025;405:1054.
    PubMed    
    
    
    
40. SILVA DS, Razum O
    COVID-19: border closures violate human rights.
    Lancet. 2025;405:1053-1054.
    PubMed    
    
    
    
41. SINGH B, Lipunga GD, Thangavelu P, Dhar S, et al
    A multifaceted intervention to improve diagnosis and early management of hospitalised patients with suspected acute brain infections in Brazil, India, and Malawi: an international multicentre intervention study.
    Lancet. 2025 Mar 10:S0140-6736(25)00263-6. doi: 10.1016/S0140-6736(25)00263.
    PubMed     Abstract available
    
    
    
42. WEISS DJ, Dzianach PA, Saddler A, Lubinda J, et al
    Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum and Plasmodium vivax malaria, 2000-22: a spatial and temporal modelling study.
    Lancet. 2025 Mar 5:S0140-6736(25)00038-8. doi: 10.1016/S0140-6736(25)00038.
    PubMed     Abstract available
    
    
    February 2025
43. WONG WC, Lin V, Fang X, Kidd M, et al
    The Lancet Commission on Transforming Primary Health Care in the Post-COVID-19 Era.
    Lancet. 2025 Feb 10:S0140-6736(25)00198-9. doi: 10.1016/S0140-6736(25)00198.
    PubMed    
    
    
    January 2025
44. MUMFORD L, Hogg R, Taylor A, Lanyon P, et al
    Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY study.
    Lancet. 2025;405:314-328.
    PubMed     Abstract available
    
    
    
45. KERR S, Robertson C, Sheikh A
    Undervaccination and severe COVID-19 outcomes - Authors' reply.
    Lancet. 2025;405:302.
    PubMed    
    
    
    
46. MORRIS JA
    Undervaccination and severe COVID-19 outcomes.
    Lancet. 2025;405:301-302.
    PubMed    
    
    
    
47. JOFFE AR
    Undervaccination and severe COVID-19 outcomes.
    Lancet. 2025;405:301.
    PubMed    
    
    
    
48. DUNCAN CJA
    Antibody testing to predict SARS-CoV-2 risk in immunocompromised people.
    Lancet. 2025;405:276-278.
    PubMed    
    
    
    
49. THORNTON J
    Every Story Matters: public voices in the COVID-19 Inquiry.
    Lancet. 2025 Jan 14:S0140-6736(25)00095-9. doi: 10.1016/S0140-6736(25)00095.
    PubMed    
    
    
    December 2024
50. RUBIN DT, Allegretti JR, Panes J, Shipitofsky N, et al
    Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.
    Lancet. 2024 Dec 17:S0140-6736(24)01927-5. doi: 10.1016/S0140-6736(24)01927.
    PubMed     Abstract available
    
    
    
51. DZAU VJ, Laitner MH, Shambaugh EL
    Strategic imperatives for health in the USA: a roadmap for the incoming presidential administration.
    Lancet. 2024;404:2371-2379.
    PubMed     Abstract available
    
    
    
52. 
    The burden of diseases, injuries, and risk factors by state in the USA, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024;404:2314-2340.
    PubMed     Abstract available
    
    
    November 2024
53. FERRANTE M, D'Haens G, Jairath V, Danese S, et al
    Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study.
    Lancet. 2024 Nov 21:S0140-6736(24)01762-8. doi: 10.1016/S0140-6736(24)01762.
    PubMed     Abstract available
    
    
    
54. DWYER-LINDGREN L, Baumann MM, Li Z, Kelly YO, et al
    Ten Americas: a systematic analysis of life expectancy disparities in the USA.
    Lancet. 2024 Nov 19:S0140-6736(24)01495-8. doi: 10.1016/S0140-6736(24)01495.
    PubMed     Abstract available
    
    
    
55. DWYER-LINDGREN L, Kendrick P, Baumann MM, Li Z, et al
    Disparities in wellbeing in the USA by race and ethnicity, age, sex, and location, 2008-21: an analysis using the Human Development Index.
    Lancet. 2024 Nov 6:S0140-6736(24)01757-4. doi: 10.1016/S0140-6736(24)01757.
    PubMed     Abstract available
    
    
    
56. ALWAN NA, Al-Aly Z
    Learning from long COVID: conceptualising action to tackle infection-associated non-communicable diseases.
    Lancet. 2024 Nov 6:S0140-6736(24)02256-6. doi: 10.1016/S0140-6736(24)02256.
    PubMed    
    
    
    
57. 
    Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990-2021: findings from the Global Burden of Disease Study 2021.
    Lancet. 2024 Nov 4:S0140-6736(24)01925-1. doi: 10.1016/S0140-6736(24)01925.
    PubMed     Abstract available
    
    
    October 2024
58. PAYNE AB, Watts JA, Mitchell PK, Dascomb K, et al
    Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis.
    Lancet. 2024;404:1547-1559.
    PubMed     Abstract available
    
    
    September 2024
59. ROMANELLO M, Costello A
    The Lancet Countdown on health and climate change: competing interests and optimism bias - Authors' reply.
    Lancet. 2024;404:1197-1198.
    PubMed    
    
    
    
60. BRINK N, Chersich MF
    The Lancet Countdown on health and climate change: competing interests and optimism bias.
    Lancet. 2024;404:1196.
    PubMed    
    
    
    
61. BUTLER CD, Combs Bowles D, Hanigan IC, Harmer A, et al
    The Lancet Countdown on health and climate change: competing interests and optimism bias.
    Lancet. 2024;404:1196-1197.
    PubMed    
    
    
    
62. ROMANELLO M, Beggs PJ, Cai W, Gordon-Strachan G, et al
    The Lancet Countdown on health and climate change: representation matters - Authors' reply.
    Lancet. 2024;404:1195-1196.
    PubMed    
    
    
    
63. STREET R, Wright CY
    The Lancet Countdown on health and climate change: representation matters.
    Lancet. 2024;404:1194.
    PubMed    
    
    
    
64. HORTON R
    Offline: Xenotransplantation-a new era beckons.
    Lancet. 2024;404:1181.
    PubMed    
    
    
    
65. ELNAKIB S, Aly S, Asi YM, Shawar YR, et al
    The humanitarian system: politics can not be avoided.
    Lancet. 2024;404:1105-1106.
    PubMed    
    
    
    
66. ST LOUIS P, Makali SL, Paul E
    Health-care workers in fragile and conflict-ridden contexts.
    Lancet. 2024;404:1105.
    PubMed    
    
    
    
67. RAUSEI S, Bertolini AG
    Cuban doctors cannot be the definitive solution for Italy.
    Lancet. 2024;404:1103.
    PubMed    
    
    
    
68. YANG X, Zhang Z, Zhang Z
    Building safe health-care environments in China: urgent challenges.
    Lancet. 2024;404:1101-1102.
    PubMed    
    
    
    
69. HWANG TJ, Trinh QD, Sokolov E
    Safe and equitable use of clinical decision support systems.
    Lancet. 2024;404:1100-1101.
    PubMed    
    
    
    
70. HORTON R
    Offline: From Wanless to Darzi-don't miss this opportunity (again).
    Lancet. 2024;404:1088.
    PubMed    
    
    
    
71. NACHEGA JB, Muyembe-Tamfum JJ, Ntoumi F, Mbala-Kingebeni P, et al
    A call for global solidarity and rapid action to control mpox.
    Lancet. 2024;404:1099-1100.
    PubMed    
    
    
    
72. 
    Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.
    Lancet. 2024 Sep 13:S0140-6736(24)01867-1. doi: 10.1016/S0140-6736(24)01867.
    PubMed     Abstract available
    
    
    
73. IMANI-MUSIMWA P, Ververs M
    Mpox and breastmilk: for once, can we act in time?
    Lancet. 2024 Sep 13:S0140-6736(24)01881-6. doi: 10.1016/S0140-6736(24)01881.
    PubMed    
    
    
    August 2024
74. MACNAUGHTON J, Zeiler K
    Reimagining illness through post-COVID-19 condition: the need for radically interdisciplinary health research.
    Lancet. 2024;404:840-841.
    PubMed    
    
    
    
75. ZAROCOSTAS J
    Many challenges for WHO-AFRO regional director candidates.
    Lancet. 2024;404:736-737.
    PubMed    
    
    
    
76. BRANDA F, Ceccarelli G, Ciccozzi M, Scarpa F, et al
    Strengthening community resilience: lessons from COVID-19 for mpox prevention.
    Lancet. 2024 Aug 22:S0140-6736(24)01752-5. doi: 10.1016/S0140-6736(24)01752.
    PubMed    
    
    
    
77. DELLGREN JL, Persad G, Emanuel EJ
    International coverage of GLP-1 receptor agonists: a review and ethical analysis of discordant approaches.
    Lancet. 2024 Aug 16:S0140-6736(24)01356-4. doi: 10.1016/S0140-6736(24)01356.
    PubMed    
    
    
    
78. SAMARASEKERA U
    Understanding pandemic risks: the WHO Pandemic Hub.
    Lancet. 2024;404:420-421.
    PubMed    
    
    
    
79. SHAH SA, Robertson C, Sheikh A
    Waiting list models must account for departures before treatment - Authors' reply.
    Lancet. 2024;404:432-433.
    PubMed    
    
    
    
80. WOOD RM
    Waiting list models must account for departures before treatment.
    Lancet. 2024;404:431-432.
    PubMed    
    
    
    
81. O'NEILL D
    Continuing challenges to health equity in Ireland.
    Lancet. 2024;404:431.
    PubMed    
    
    
    
82. BANATVALA JE, Muir P, Irving W, Meader E, et al
    The role of the clinical virologist in pandemic responses.
    Lancet. 2024;404:430.
    PubMed    
    
    
    
83. GARAY J, Kateeb E, Zeballos D, Souza LE, et al
    Inequity in sustainable health today.
    Lancet. 2024;404:429-430.
    PubMed    
    
    
    
84. GREEN A
    Evelyn Fox Keller.
    Lancet. 2024;404:426.
    PubMed    
    
    
    July 2024
85. GREENHALGH T, Sivan M, Perlowski A, Nikolich JZ, et al
    Long COVID: a clinical update.
    Lancet. 2024 Jul 31:S0140-6736(24)01136-X. doi: 10.1016/S0140-6736(24)01136.
    PubMed     Abstract available
    
    
    
86. TRIUNFOL M
    Charges brought in Brazilian COVID-19 malpractice case.
    Lancet. 2024;404:325-326.
    PubMed    
    
    
    
87. BISSONNETTE R, Warren RB, Pinter A, Agner T, et al
    Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials.
    Lancet. 2024 Jul 18:S0140-6736(24)01027-4. doi: 10.1016/S0140-6736(24)01027.
    PubMed     Abstract available
    
    
    
88. FRANZ C, Holzscheiter A, Kickbusch I
    Germany's role in global health at a critical juncture.
    Lancet. 2024;404:82-94.
    PubMed     Abstract available
    
    
    June 2024
89. SAMARASEKERA U
    No parties meeting the challenge on health in the UK.
    Lancet. 2024;403:2769-2770.
    PubMed    
    
    
    
90. DIEDRICH L
    Illness politics and social media mobilisation.
    Lancet. 2024;403:2776-2777.
    PubMed    
    
    
    
91. THE LANCET
    UK elections: the need for a healthy change.
    Lancet. 2024;403:2755.
    PubMed    
    
    
    
92. GARCIA PJ, Saavedra J, Espinoza-Pajuelo L, Garcia-Terron FA, et al
    Why Latin America needs a regional Centre for Disease Control and Prevention.
    Lancet. 2024;403:2763-2765.
    PubMed    
    
    
    
93. HIRST JE, Witt A, Mullins E, Womersley K, et al
    Delivering the promise of improved health for women and girls in England.
    Lancet. 2024 Jun 27:S0140-6736(24)01347-3. doi: 10.1016/S0140-6736(24)01347.
    PubMed    
    
    
    
94. HO A, Galgut O, Faustini S, Peters N, et al
    Implications of suboptimal measles immunity in UK health-care workers.
    Lancet. 2024 Jun 26:S0140-6736(24)01011-0. doi: 10.1016/S0140-6736(24)01011.
    PubMed    
    
    
    
95. SCHRECKER T
    Canada's reckoning?
    Lancet. 2024;403:2688.
    PubMed    
    
    
    
96. ZAROCOSTAS J
    Mental health in emergencies requires "a major rethink".
    Lancet. 2024;403:2582.
    PubMed    
    
    
    
97. AHSAN S
    Israel border closure denying health care to Gazans.
    Lancet. 2024;403:2581.
    PubMed    
    
    
    
98. SAMARASEKERA U
    African vaccine manufacturing scheme to boost production.
    Lancet. 2024;403:2579-2580.
    PubMed    
    
    
    
99. KUNKLER I
    Improving future UK pandemic management structure.
    Lancet. 2024;403:2592.
    PubMed    
    
    
    
100. YOON JH, Kwon IH, Park HW
     The South Korean health-care system in crisis.
     Lancet. 2024;403:2589.
     PubMed    
     
     
     
101. THE LANCET
     Taking persistent physical symptoms seriously.
     Lancet. 2024;403:2565.
     PubMed    
     
     
     
102. MCCALL C
     Security concerns threaten Papua New Guinea relief efforts.
     Lancet. 2024;403:2471.
     PubMed    
     
     
     
103. KOMAMURA K, Iwase M
     Clinical outcomes of the AdaptResponse trial.
     Lancet. 2024;403:2484.
     PubMed    
     
     
     
104. FILIPPATOS G, Gold MR, Mullens W, Kusano K, et al
     Clinical outcomes of the AdaptResponse trial - Authors' reply.
     Lancet. 2024;403:2484-2485.
     PubMed    
     
     
     
105. HORTON R
     Offline: The system is not working.
     Lancet. 2024;403:2470.
     PubMed    
     
     
     
106. MOHAPATRA PR
     Responding to India's data and transparency.
     Lancet. 2024;403:2482-2483.
     PubMed    
     
     
     
107. ANIRVAN P
     Blowing in the wind-India's health data and transparency issues.
     Lancet. 2024;403:2483-2484.
     PubMed    
     
     
     
108. KELLY P, Lemmens R, Weimar C, Walsh C, et al
     Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial.
     Lancet. 2024 Jun 7:S0140-6736(24)00968-1. doi: 10.1016/S0140-6736(24)00968.
     PubMed     Abstract available
     
     
     
109. WATTS G
     Martin Raw.
     Lancet. 2024;403:2372.
     PubMed    
     
     
     
110. SAMARASEKERA U
     Calls for a focus on health risks in EU election.
     Lancet. 2024;403:2364.
     PubMed    
     
     
     
111. TORNINI VA, Fernandez RW, Goldman OV, Suarez J, et al
     DEI infrastructures required for the best science and medicine.
     Lancet. 2024;403:2375.
     PubMed    
     
     
     
112. HORTON R
     Offline: UK election-two issues you won't hear about.
     Lancet. 2024;403:2362.
     PubMed    
     
     
     May 2024
113. PATERLINI M
     Warnings over Italian health-care devolution.
     Lancet. 2024;403:2279.
     PubMed    
     
     
     
114. THORNTON J
     Infected blood report release marks a day of shame for the UK.
     Lancet. 2024;403:2276-2277.
     PubMed    
     
     
     
115. THE LANCET
     Cyberattacks on health care-a growing threat.
     Lancet. 2024;403:2263.
     PubMed    
     
     
     
116. KIMBALL AB, Jemec GBE, Sayed CJ, Kirby JS, et al
     Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials.
     Lancet. 2024 May 22:S0140-6736(24)00101-6. doi: 10.1016/S0140-6736(24)00101.
     PubMed     Abstract available
     
     
     
117. LAXMINARAYAN R, Impalli I, Rangarajan R, Cohn J, et al
     Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance.
     Lancet. 2024 May 20:S0140-6736(24)00878-X. doi: 10.1016/S0140-6736(24)00878.
     PubMed     Abstract available
     
     
     
118. SAMARASEKERA U
     50 years of the Expanded Programme on Immunization.
     Lancet. 2024;403:1971-1972.
     PubMed    
     
     
     
119. 
     Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.
     Lancet. 2024;403:2204-2256.
     PubMed     Abstract available
     
     
     
120. MARCATO AJ, Meagher N, Spirkoska V, Arnott A, et al
     One Health pandemic preparedness: the role of companion animals in disease transmission.
     Lancet. 2024;403:1984-1985.
     PubMed    
     
     
     
121. ADAMU AA, Ndwandwe D, Jalo RI, Muhammad ID, et al
     Cofinancing immunisation through national health insurance.
     Lancet. 2024;403:1983-1984.
     PubMed    
     
     
     
122. HORTON R
     Offline: Indifference-the biggest threat to global health.
     Lancet. 2024;403:1970.
     PubMed    
     
     
     
123. KANTER R, Fort MP
     Rethinking health policy: life expectancy and mortality in an era of polycrisis.
     Lancet. 2024;403:1956-1958.
     PubMed    
     
     
     
124. WATTS G
     Alasdair Macintosh Geddes.
     Lancet. 2024;403:1846.
     PubMed    
     
     
     
125. AUJLA M
     Art, plunder, fragile fault lines.
     Lancet. 2024;403:1844-1845.
     PubMed    
     
     
     
126. USHER AD
     Organisations vie for control over pandemic financing.
     Lancet. 2024;403:1839-1840.
     PubMed    
     
     
     
127. GREENHALGH T, MacIntyre CR, Ungrin M, Wright JM, et al
     Airborne pathogens: controlling words won't control transmission.
     Lancet. 2024;403:1850-1851.
     PubMed    
     
     
     
128. YANG YT
     Protecting humanitarian aid workers: an urgent call.
     Lancet. 2024;403:1847.
     PubMed    
     
     
     
129. ABUZERR S, Zinser K
     Amplifying the voices of women in the Gaza Strip.
     Lancet. 2024;403:1848-1849.
     PubMed    
     
     
     
130. KNUPPEL A, Boyd A, Macleod J, Chaturvedi N, et al
     The long COVID evidence gap in England.
     Lancet. 2024 May 6:S0140-6736(24)00744-X. doi: 10.1016/S0140-6736(24)00744.
     PubMed    
     
     
     
131. KIVIMAKI M, Batty GD
     Work as a health risk.
     Lancet. 2024;403:1747-1748.
     PubMed    
     
     
     April 2024
132. GREEN A
     Tobias Welte.
     Lancet. 2024;403:1626.
     PubMed    
     
     
     
133. ADEPOJU P
     Moderna stalls on African vaccine manufacturing plans.
     Lancet. 2024;403:1617.
     PubMed    
     
     
     
134. MARCHALIK D, Rehm D
     On not cutting corners.
     Lancet. 2024;403:1623.
     PubMed    
     
     
     
135. DEVI S
     Swedish NGOs are reeling after government cuts.
     Lancet. 2024;403:1527.
     PubMed    
     
     
     
136. 
     Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a sys
     Lancet. 2024 Apr 15:S0140-6736(24)00757-8. doi: 10.1016/S0140-6736(24)00757.
     PubMed     Abstract available
     
     
     
137. ZUMLA A, Peiris M, Memish ZA, Perlman S, et al
     Anticipating a MERS-like coronavirus as a potential pandemic threat.
     Lancet. 2024 Apr 8:S0140-6736(24)00641-X. doi: 10.1016/S0140-6736(24)00641.
     PubMed    
     
     
     
138. PETO L, Basnyat B, Horby P
     High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' reply.
     Lancet. 2024;403:1339-1340.
     PubMed    
     
     
     
139. BHUSAL S, Adhikari S
     High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
     Lancet. 2024;403:1339.
     PubMed    
     
     
     
140. NARASARAJU T, Ravi Y, Jonsson CB, Chow VTK, et al
     High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
     Lancet. 2024;403:1338-1339.
     PubMed    
     
     
     
141. HSU NC, Tokuda Y
     High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
     Lancet. 2024;403:1338.
     PubMed    
     
     
     
142. MCEVOY N, Lowry J, O'Dowd A, Curley GF, et al
     High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
     Lancet. 2024;403:1337.
     PubMed    
     
     
     
143. HASHIM Z, Nath A, Tripathy NK
     High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
     Lancet. 2024;403:1337-1338.
     PubMed    
     
     
     
144. SORAAS A, Brunvoll SH, Nygaard AB, Dahl JA, et al
     Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan.
     Lancet. 2024;403:1336.
     PubMed    
     
     
     
145. GU X, Huang L, Zhang H, Cao B, et al
     Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan - Authors' reply.
     Lancet. 2024;403:1336-1337.
     PubMed    
     
     
     
146. 
     Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
     Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367.
     PubMed     Abstract available
     
     
     March 2024
147. KULKARNI PS, Potey AV, Bharati S, Kunhihitlu A, et al
     The safety and immunogenicity of a bivalent conjugate vaccine against Salmonella enterica Typhi and Paratyphi A in healthy Indian adults: a phase 1, randomised, active-controlled, double-blind trial.
     Lancet. 2024 Mar 28:S0140-6736(24)00249-6. doi: 10.1016/S0140-6736(24)00249.
     PubMed     Abstract available
     
     
     
148. SZANYI J, Howe S, Blakely T
     The importance of reporting accurate estimates of long COVID prevalence.
     Lancet. 2024;403:1136-1137.
     PubMed    
     
     
     
149. WENHAM C, Stout L
     A legal mapping of 48 WHO member states' inclusion of public health emergency of international concern, pandemic, and health emergency terminology within national emergency legislation in responding to health emergencies.
     Lancet. 2024 Mar 22:S0140-6736(24)00156-9. doi: 10.1016/S0140-6736(24)00156.
     PubMed     Abstract available
     
     
     
150. SHAWE-TAYLOR M, Greenwood D, Hobbs A, Dowgier G, et al
     Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign.
     Lancet. 2024 Mar 11:S0140-6736(24)00316-7. doi: 10.1016/S0140-6736(24)00316.
     PubMed    
     
     
     
151. 
     Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden
     Lancet. 2024 Mar 8:S0140-6736(24)00476-8. doi: 10.1016/S0140-6736(24)00476.
     PubMed     Abstract available
     
     
     
152. PARHIZ H, Atochina-Vasserman EN, Weissman D
     mRNA-based therapeutics: looking beyond COVID-19 vaccines.
     Lancet. 2024 Mar 7:S0140-6736(23)02444-3. doi: 10.1016/S0140-6736(23)02444.
     PubMed     Abstract available
     
     
     February 2024
153. DHAIRYAWAN R
     Candour, care, and COVID-19.
     Lancet. 2024;403:718.
     PubMed    
     
     
     
154. VORA NM, Hassan L, Plowright RK, Horton R, et al
     The Lancet-PPATS Commission on Prevention of Viral Spillover: reducing the risk of pandemics through primary prevention.
     Lancet. 2024;403:597-599.
     PubMed    
     
     
     
155. WALLER BY, Joseph VA, Keyes KM
     Racial inequities in homicide rates and homicide methods among Black and White women aged 25-44 years in the USA, 1999-2020: a cross-sectional time series study.
     Lancet. 2024 Feb 8:S0140-6736(23)02279-1. doi: 10.1016/S0140-6736(23)02279.
     PubMed     Abstract available
     
     
     January 2024
156. MCCLOSKEY B, Saito T, Shimada S, Ikenoue C, et al
     The Tokyo 2020 and Beijing 2022 Olympic Games held during the COVID-19 pandemic: planning, outcomes, and lessons learnt.
     Lancet. 2024 Jan 17:S0140-6736(23)02635-1. doi: 10.1016/S0140-6736(23)02635.
     PubMed     Abstract available
     
     
     
157. WANG L, Wang Q, Gao GF
     Interpreting COVID-19 data from China: a call for caution - Authors' reply.
     Lancet. 2024;403:144-145.
     PubMed    
     
     
     
158. QU Z
     Interpreting COVID-19 data from China: a call for caution.
     Lancet. 2024;403:144.
     PubMed    
     
     
     
159. GULLIFORD MC, Steves CJ
     Access to COVID-19 vaccination and COVID-19-related hospital admissions and mortality.
     Lancet. 2024 Jan 12:S0140-6736(23)02622-3. doi: 10.1016/S0140-6736(23)02622.
     PubMed    
     
     
     
160. 
     Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort studies in England, Northern Ireland, Scotland, and Wales.
     Lancet. 2024 Jan 12:S0140-6736(23)02467-4. doi: 10.1016/S0140-6736(23)02467.
     PubMed     Abstract available
     
     
     
161. SHAH SA, Robertson C, Sheikh A
     Effects of the COVID-19 pandemic on NHS England waiting times for elective hospital care: a modelling study.
     Lancet. 2024 Jan 11:S0140-6736(23)02744-7. doi: 10.1016/S0140-6736(23)02744.
     PubMed    
     
     
     December 2023
162. 
     How modelling can better support public health policy making: the Lancet Commission on Strengthening the Use of Epidemiological Modelling of Emerging and Pandemic Infectious Diseases.
     Lancet. 2023 Dec 20:S0140-6736(23)02758-7. doi: 10.1016/S0140-6736(23)02758.
     PubMed    
     
     
     
163. GILES-VERNICK T, Cheah PY, Matta G, Lima NT, et al
     Louis Pasteur, COVID-19, and the social challenges of epidemics.
     Lancet. 2023;400:2166-2168.
     PubMed    
     
     
     
164. CHARLIER P
     Death and end of life in France after COVID-19.
     Lancet. 2023;402:2290.
     PubMed    
     
     
     
165. HORTON R
     Offline: Boris Johnson and COVID-19-more light than heat.
     Lancet. 2023;402:2277.
     PubMed    
     
     
     November 2023
166. POESPOPRODJO JR, Douglas NM, Ansong D, Kho S, et al
     Malaria.
     Lancet. 2023 Nov 1:S0140-6736(23)01249-7. doi: 10.1016/S0140-6736(23)01249.
     PubMed     Abstract available
     
     
     
167. ZIAUDDEEN N, Pantelic M, O'Hara ME, Hastie C, et al
     Impact of long COVID-19 on work: a co-produced survey.
     Lancet. 2023;402 Suppl 1:S98.
     PubMed     Abstract available
     
     
     
168. VAN YPEREN J, Campillo-Funollet E, Memon A, Allman P, et al
     The Sussex COVID-19 Modelling Cell: the methods and successes of a collaboration between public health teams in local authorities, NHS hospital trusts, NHS commissioners, and universities.
     Lancet. 2023;402 Suppl 1:S94.
     PubMed     Abstract available
     
     
     
169. WRENN K, Blomquist PB, Inzoungou-Massanga C, Olufon O, et al
     Surge of lower respiratory tract group A streptococcal infections in England in winter 2022: epidemiology and clinical profile.
     Lancet. 2023;402 Suppl 1:S93.
     PubMed     Abstract available
     
     
     
170. RAMASAWMY M, Khan N, Sunkersing D, Banerjee A, et al
     Understanding ethnic inequalities in the design and implementation of digital health interventions for cardiometabolic disease: a qualitative study.
     Lancet. 2023;402 Suppl 1:S78.
     PubMed     Abstract available
     
     
     
171. 
     Nowcasting waiting lists for elective procedures and surgery in England: a modelling study.
     Lancet. 2023;402 Suppl 1:S74.
     PubMed     Abstract available
     
     
     
172. MURPHY MH, O'Kane SM, Carlin A, Lahart IM, et al
     A peer-led walking intervention for adolescent girls (the WISH study): a cluster-randomised controlled trial.
     Lancet. 2023;402 Suppl 1:S72.
     PubMed     Abstract available
     
     
     
173. MORENO-AGOSTINO D, Das-Munshi J, Ploubidis GB
     Differences in the impact of the COVID-19 pandemic in the long-term trajectories of life satisfaction by sex in the UK: a prospective cohort study.
     Lancet. 2023;402 Suppl 1:S71.
     PubMed     Abstract available
     
     
     
174. MARTIN A, Jamieson S
     Exploring the experiences of junior doctors who were shielding during the COVID-19 pandemic: a qualitative study of semi-structured interviews.
     Lancet. 2023;402 Suppl 1:S68.
     PubMed     Abstract available
     
     
     
175. KROMYDAS T, Demou E, Leyland AH, Katikireddi SV, et al
     Effect of trade unions on the mental health of UK workers before and during the COVID-19 pandemic: a longitudinal analysis using Understanding Society data.
     Lancet. 2023;402 Suppl 1:S62.
     PubMed     Abstract available
     
     
     
176. KHAN Y, Verhaeghe N, Devleesschauwer B, Cavillot L, et al
     Impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in Europe: a systematic review.
     Lancet. 2023;402 Suppl 1:S61.
     PubMed     Abstract available
     
     
     
177. KALBUS A, Cornelsen L, Ballatore A, Cummins S, et al
     Changes in food and drink purchasing behaviour in England during the first 3 months of the COVID-19 pandemic: an interrupted time-series analysis.
     Lancet. 2023;402 Suppl 1:S60.
     PubMed     Abstract available
     
     
     
178. HINDOCHA A, Brennan L, Brewster L, Lunn J, et al
     The wider health and wellbeing needs of those accessing paediatric care in England: engaging with the hidden voices of children and young people.
     Lancet. 2023;402 Suppl 1:S50.
     PubMed     Abstract available
     
     
     
179. HAZIR SG, Ryan C, Moore A, Lewis C, et al
     The role of the multiple Index of deprivation in predicting mental health outcomes after the COVID-19 pandemic in adolescents: a cross-sectional study.
     Lancet. 2023;402 Suppl 1:S47.
     PubMed     Abstract available
     
     
     
180. DU Z, Wang L, Bai Y, Pei Y, et al
     Mitigation of respiratory syncytial virus epidemics by RSVpreF vaccines after the COVID-19 pandemic in the UK: a modelling study.
     Lancet. 2023;402 Suppl 1:S39.
     PubMed     Abstract available
     
     
     
181. DOBBIN J, Soares CA, Burns F, Miall N, et al
     Medical consequences of "contingency accommodation" for people seeking asylum: thematic analysis of a survey from professionals working in contingency accommodation.
     Lancet. 2023;402 Suppl 1:S38.
     PubMed     Abstract available
     
     
     
182. ARNOTT J, Troya MI, Joyce M, Khashan A, et al
     Untangling the association between COVID-19 health literacy, trust in the pandemic response, and mental distress, during the COVID-19 pandemic in Ireland: a repeated cross-sectional study.
     Lancet. 2023;402 Suppl 1:S23.
     PubMed     Abstract available
     
     
     
183. ACHARYA A, Darzi A, Judah G
     An SMS and animated video intervention to increase uptake of breast cancer screening: a randomised controlled trial.
     Lancet. 2023;402 Suppl 1:S17.
     PubMed     Abstract available
     
     
     October 2023
184. WANG Q, Bowen A, Ho J, Zhang RM, et al
     SARS-CoV-2 neutralising antibodies after a second BA.5 bivalent booster.
     Lancet. 2023 Oct 31:S0140-6736(23)02278-X. doi: 10.1016/S0140-6736(23)02278.
     PubMed    
     
     
     
185. ABBASI K, Ali P, Barbour V, Benfield T, et al
     Time to treat the climate and nature crisis as one indivisible global health emergency.
     Lancet. 2023 Oct 25:S0140-6736(23)02289-4. doi: 10.1016/S0140-6736(23)02289.
     PubMed    
     
     
     
186. FRANK J, Mustard C, Smith P, Siddiqi A, et al
     Work as a social determinant of health in high-income countries: past, present, and future.
     Lancet. 2023;402:1357-1367.
     PubMed     Abstract available
     
     
     
187. DELFRAISSY JF, Horgan M, Molbak K, Simon FS, et al
     Scientific advisory councils in the COVID-19 response.
     Lancet. 2023 Oct 12:S0140-6736(23)01846-9. doi: 10.1016/S0140-6736(23)01846.
     PubMed    
     
     
     September 2023
188. HOCHMAYR C, Kiechl-Kohlendorfer U, Griesmaier E
     COVID toes, newborn blue toes, and prepartum SARS-CoV-2 infection - Authors' reply.
     Lancet. 2023;402:1132.
     PubMed    
     
     
     
189. MATUCHANSKY C
     Natural SARS-CoV-2 infection-induced immune protection against re-infection.
     Lancet. 2023;402:1131.
     PubMed    
     
     
     
190. ZHOU YB, Xu ZG
     COVID toes, newborn blue toes, and prepartum SARS-CoV-2 infection.
     Lancet. 2023;402:1131-1132.
     PubMed    
     
     
     
191. QU Z
     Cautionary notes on the COVID-19 re-infection study.
     Lancet. 2023;402:1130-1131.
     PubMed    
     
     
     
192. FLACCO ME, Martellucci CA, Manzoli L
     Extra data to confirm waning protection of omicron (B.1.1.529) natural immunity.
     Lancet. 2023;402:1129.
     PubMed    
     
     
     
193. YANG C, Lapp L, Tebbutt SJ
     Overcoming COVID-19 vaccine hesitancy hurdles.
     Lancet. 2023;402:1129-1130.
     PubMed    
     
     
     
194. TSAGKARIS C, Papazoglou AS, Moysidis DV, Papadakos SP, et al
     Striving to afford free health care in Greece during COVID-19.
     Lancet. 2023;402:1128-1129.
     PubMed    
     
     
     
195. PALUMBO L, Picchio CA, Smallwood C, Salvi C, et al
     Community COVID-19 response in WHO's European region.
     Lancet. 2023;402:1127.
     PubMed    
     
     
     
196. UMAR TP
     Arcturus (XBB.1.16) COVID-19 subvariant emergence in Indonesia.
     Lancet. 2023;402:1127-1128.
     PubMed    
     
     
     
197. JASSAT W, Reyes LF, Munblit D, Caoili J, et al
     Long COVID in low-income and middle-income countries: the hidden public health crisis.
     Lancet. 2023;402:1115-1117.
     PubMed    
     
     
     
198. MASSUDA A, Dall'Alba R, Chioro A, Temporao JG, et al
     Bolsonaro's Ministry of Health's response to COVID-19 and other health challenges - Authors' reply.
     Lancet. 2023;402:1041-1042.
     PubMed    
     
     
     
199. PARENTE RCM, Queiroga M
     Bolsonaro's Ministry of Health's response to COVID-19 and other health challenges.
     Lancet. 2023;402:1040-1041.
     PubMed    
     
     
     
200. ZHANG H
     COVID-19 and Chinese nurses' mental health.
     Lancet. 2023;402:1039-1040.
     PubMed    
     
     
     
201. HEYMANS S, Lakdawala NK, Tschope C, Klingel K, et al
     Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches.
     Lancet. 2023;402:998-1011.
     PubMed     Abstract available
     
     
     
202. DZAU V, Swaminathan S, Baker C, Bright RA, et al
     The 100 Days Mission: how a new medical-countermeasures network can deliver equity and innovation.
     Lancet. 2023 Sep 5:S0140-6736(23)01775-0. doi: 10.1016/S0140-6736(23)01775.
     PubMed    
     
     
     
203. PERCIVAL V, Thoms OT, Oppenheim B, Rowlands D, et al
     The Lancet Commission on peaceful societies through health equity and gender equality.
     Lancet. 2023 Sep 4:S0140-6736(23)01348-X. doi: 10.1016/S0140-6736(23)01348.
     PubMed    
     
     
     August 2023
204. DAI L, Duan H, Liu X, Zhou H, et al
     Omicron neutralisation: RBD-dimer booster versus BF.7 and BA.5.2 breakthrough infection.
     Lancet. 2023;402:687-689.
     PubMed    
     
     
     
205. KUNG S, Hills T, Kearns N, Beasley R, et al
     New Zealand's COVID-19 elimination strategy and mortality patterns.
     Lancet. 2023 Aug 24:S0140-6736(23)01368-5. doi: 10.1016/S0140-6736(23)01368.
     PubMed    
     
     
     
206. IFTEKHAR N, Sivan M
     Venous insufficiency and acrocyanosis in long COVID: dysautonomia.
     Lancet. 2023;402:e9.
     PubMed    
     
     
     
207. KNAUL FM, Arreola-Ornelas H, Touchton M, McDonald T, et al
     Setbacks in the quest for universal health coverage in Mexico: polarised politics, policy upheaval, and pandemic disruption.
     Lancet. 2023 Aug 7:S0140-6736(23)00777-8. doi: 10.1016/S0140-6736(23)00777.
     PubMed     Abstract available
     
     
     July 2023
208. HSU NC, Hsu CH
     COVID-19 and commerce complicate minimum unit pricing effects on health.
     Lancet. 2023;402:368.
     PubMed    
     
     
     
209. WYPER GM, Mackay DF, Fraser C, Lewsey J, et al
     COVID-19 and commerce complicate minimum unit pricing effects on health - Authors' reply.
     Lancet. 2023;402:368-369.
     PubMed    
     
     
     
210. 
     Pandemics move faster than funders.
     Lancet. 2023;402:367.
     PubMed    
     
     
     
211. ZHOU J, Zhang Y, Mo K, Newbert H, et al
     mRNA vaccines do not stop with COVID-19.
     Lancet. 2023 Jul 27:S0140-6736(23)01514-3. doi: 10.1016/S0140-6736(23)01514.
     PubMed    
     
     
     
212. O'BRIEN KL, Lemango E
     The big catch-up in immunisation coverage after the COVID-19 pandemic: progress and challenges to achieving equitable recovery.
     Lancet. 2023 Jul 17:S0140-6736(23)01468-X. doi: 10.1016/S0140-6736(23)01468.
     PubMed    
     
     
     
213. RIFE EC, Cron RQ
     Janus kinase inhibition in juvenile idiopathic arthritis.
     Lancet. 2023 Jul 6:S0140-6736(23)01134-0. doi: 10.1016/S0140-6736(23)01134.
     PubMed    
     
     
     June 2023
214. 
     The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019.
     Lancet. 2023 Jun 29:S0140-6736(23)00860-7. doi: 10.1016/S0140-6736(23)00860.
     PubMed     Abstract available
     
     
     
215. WIJAYA R, Johnson M, Campbell N, Stuart B, et al
     Predicting COVID-19 infection risk in people who are immunocompromised by antibody testing.
     Lancet. 2023 Jun 29:S0140-6736(23)01180-7. doi: 10.1016/S0140-6736(23)01180.
     PubMed    
     
     
     
216. PELOSI A
     Disrespectful language about patients with long COVID.
     Lancet. 2023;401:2108.
     PubMed    
     
     
     
217. PRIYA GIRI S, Dubey A
     Loneliness in the time of COVID-19: an alarming rise.
     Lancet. 2023;401:2107-2108.
     PubMed    
     
     
     
218. BAILEY C, Sanderson T, Townsley H, Goldman J, et al
     Independent SARS-CoV-2 staff testing protected academic and health-care institutions in northwest London.
     Lancet. 2023 Jun 19:S0140-6736(23)00917-0. doi: 10.1016/S0140-6736(23)00917.
     PubMed    
     
     
     
219. LEGIDO-QUIGLEY H, Clark H, Nishtar S, Horton R, et al
     Reimagining health security and preventing future pandemics: the NUS-Lancet Pandemic Readiness, Implementation, Monitoring, and Evaluation Commission.
     Lancet. 2023;401:2021-2023.
     PubMed    
     
     
     
220. HUANG C, Huang L, Wang Y, Li X, et al
     6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
     Lancet. 2023 Jun 12:S0140-6736(23)00810-3. doi: 10.1016/S0140-6736(23)00810.
     PubMed     Abstract available
     
     
     
221. PLATZBECKER U, Della Porta MG, Santini V, Zeidan AM, et al
     Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.
     Lancet. 2023 Jun 9:S0140-6736(23)00874-7. doi: 10.1016/S0140-6736(23)00874.
     PubMed     Abstract available
     
     
     
222. THE LANCET EDITORS
     Retraction and republication: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
     Lancet. 2023 Jun 9:S0140-6736(23)01175-3. doi: 10.1016/S0140-6736(23)01175.
     PubMed    
     
     
     
223. WOLF J, Johnston RB, Ambelu A, Arnold BF, et al
     Burden of disease attributable to unsafe drinking water, sanitation, and hygiene in domestic settings: a global analysis for selected adverse health outcomes.
     Lancet. 2023 Jun 5:S0140-6736(23)00458-0. doi: 10.1016/S0140-6736(23)00458.
     PubMed     Abstract available
     
     
     May 2023
224. JAFFE S
     US health experts divided on social media age restrictions.
     Lancet. 2023;401:1757.
     PubMed    
     
     
     
225. 
     Learning from serosurveillance for SARS-CoV-2 to inform pandemic preparedness and response.
     Lancet. 2023 May 26:S0140-6736(23)00964-9. doi: 10.1016/S0140-6736(23)00964.
     PubMed    
     
     
     
226. FLAHAULT A, Calmy A, Costagliola D, Drapkina O, et al
     No time for complacency on COVID-19 in Europe.
     Lancet. 2023 May 22:S0140-6736(23)01012-7. doi: 10.1016/S0140-6736(23)01012.
     PubMed    
     
     
     
227. ZAROCOSTAS J
     With the COVID-19 PHEIC over, what next?
     Lancet. 2023;401:1642-1643.
     PubMed    
     
     
     
228. MFINANGA SG, Gatei W, Tinuga F, Mwengee WMP, et al
     Tanzania's COVID-19 vaccination strategy: lessons, learning, and execution.
     Lancet. 2023;401:1649.
     PubMed    
     
     
     
229. JAFFE S
     US Surgeon General: loneliness is a public health crisis.
     Lancet. 2023;401:1560.
     PubMed    
     
     
     
230. EMANUEL EJ, Persad G
     The shared ethical framework to allocate scarce medical resources: a lesson from COVID-19.
     Lancet. 2023 May 9:S0140-6736(23)00812-7. doi: 10.1016/S0140-6736(23)00812.
     PubMed     Abstract available
     
     
     April 2023
231. AGRAWAL U, Robertson C, Sheikh A
     Moving towards a precision approach for prevention of severe COVID-19 - Authors' reply.
     Lancet. 2023;401:1424.
     PubMed    
     
     
     
232. BRANCH-ELLIMAN W, Monach PA
     Moving towards a precision approach for prevention of severe COVID-19.
     Lancet. 2023;401:1423-1424.
     PubMed    
     
     
     
233. SZAPOCZNIK J, Faviero G, Dansua AS, Bausch DG, et al
     The importance of accountability in tackling future pandemics.
     Lancet. 2023;401:1423.
     PubMed    
     
     
     
234. GALVAO J
     COVID-19: forgetting a pandemic that is not over.
     Lancet. 2023;401:1422-1423.
     PubMed    
     
     
     
235. THE LANCET
     Moving past the COVID-19 emergency in the USA.
     Lancet. 2023;401:1399.
     PubMed    
     
     
     
236. ROSS I, Bick S, Ayieko P, Dreibelbis R, et al
     Effectiveness of handwashing with soap for preventing acute respiratory infections in low-income and middle-income countries: a systematic review and meta-analysis.
     Lancet. 2023 Apr 27:S0140-6736(23)00021-1. doi: 10.1016/S0140-6736(23)00021.
     PubMed     Abstract available
     
     
     
237. CUENI T
     Lessons learned from COVID-19 to stop future pandemics.
     Lancet. 2023;401:1340.
     PubMed    
     
     
     
238. HORTON R
     Offline: The UK COVID-19 Inquiry-be patient, but don't wait.
     Lancet. 2023;401:1324.
     PubMed    
     
     
     
239. LURIE N, Sharfstein JM
     State-to-state differences in US COVID-19 outcomes: searching for explanations.
     Lancet. 2023;401:1314-1315.
     PubMed    
     
     
     
240. PETROV AN, Dorough DS, Tiwari S, Welford M, et al
     Indigenous health-care sovereignty defines resilience to the COVID-19 pandemic.
     Lancet. 2023 Apr 18:S0140-6736(23)00684-0. doi: 10.1016/S0140-6736(23)00684.
     PubMed    
     
     
     
241. HOCHMAYR C, Auckenthaler M, Fink FM, Kiechl-Kohlendorfer U, et al
     Differential diagnosis of blue toes in a newborn baby: might have been maternal infection with COVID-19?
     Lancet. 2023;401:e20.
     PubMed    
     
     
     
242. GOH AXC, Chae SR, Chiew CJ, Tang N, et al
     Characteristics of the omicron XBB subvariant wave in Singapore.
     Lancet. 2023;401:1261-1262.
     PubMed    
     
     
     
243. KING B, Zhang X, Harcha WG, Szepietowski JC, et al
     Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial.
     Lancet. 2023 Apr 13:S0140-6736(23)00222-2. doi: 10.1016/S0140-6736(23)00222.
     PubMed     Abstract available
     
     
     
244. 
     Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
     Lancet. 2023 Apr 12:S0140-6736(23)00510-X. doi: 10.1016/S0140-6736(23)00510.
     PubMed     Abstract available
     
     
     
245. PERNER A, Venkatesh B
     Higher-dose dexamethasone for patients with COVID-19 and hypoxaemia?
     Lancet. 2023 Apr 12:S0140-6736(23)00587-1. doi: 10.1016/S0140-6736(23)00587.
     PubMed    
     
     
     March 2023
246. THE EDITORS OF THE LANCET
     Retraction-Chinese medical personnel after the COVID-19 pandemic.
     Lancet. 2023;401:1141.
     PubMed    
     
     
     
247. SUN L, Jia H, Yang T
     Chinese medical personnel after the COVID-19 pandemic.
     Lancet. 2023;401:1000.
     PubMed    
     
     
     
248. FRIEL S, Collin J, Daube M, Depoux A, et al
     Commercial determinants of health: future directions.
     Lancet. 2023 Mar 22:S0140-6736(23)00011-9. doi: 10.1016/S0140-6736(23)00011.
     PubMed     Abstract available
     
     
     
249. GILMORE AB, Fabbri A, Baum F, Bertscher A, et al
     Defining and conceptualising the commercial determinants of health.
     Lancet. 2023 Mar 22:S0140-6736(23)00013-2. doi: 10.1016/S0140-6736(23)00013.
     PubMed     Abstract available
     
     
     
250. BOLLYKY TJ, Castro E, Aravkin AY, Bhangdia K, et al
     Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis.
     Lancet. 2023 Mar 22:S0140-6736(23)00461-0. doi: 10.1016/S0140-6736(23)00461.
     PubMed     Abstract available
     
     
     
251. 
     Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis.
     Lancet. 2023;401:833-842.
     PubMed     Abstract available
     
     
     
252. COHEN C, Pulliam J
     COVID-19 infection, reinfection, and the transition to endemicity.
     Lancet. 2023;401:798-800.
     PubMed    
     
     
     
253. QU Z
     International cooperation to end the COVID-19 pandemic.
     Lancet. 2023;401:820.
     PubMed    
     
     
     
254. THE LANCET
     Long COVID: 3 years in.
     Lancet. 2023;401:795.
     PubMed    
     
     
     
255. CARPIANO RM, Callaghan T, DiResta R, Brewer NT, et al
     Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era.
     Lancet. 2023 Mar 2:S0140-6736(23)00136-8. doi: 10.1016/S0140-6736(23)00136.
     PubMed    
     
     
     February 2023
256. HUANG S, Gao Z, Wang S
     China's COVID-19 reopening measures-warriors and weapons.
     Lancet. 2023;401:643-644.
     PubMed    
     
     
     
257. HAY SI, Murray CJL
     Conflicting COVID-19 excess mortality estimates - Authors' reply.
     Lancet. 2023;401:433-434.
     PubMed    
     
     
     
258. BAGER P, Nielsen J, Bhatt S, Nielsen LB, et al
     Conflicting COVID-19 excess mortality estimates.
     Lancet. 2023;401:432-433.
     PubMed    
     
     
     
259. DONZELLI A
     Conflicting COVID-19 excess mortality estimates.
     Lancet. 2023;401:432.
     PubMed    
     
     
     
260. MOETI M, Makubalo L, Gueye AS, Balde T, et al
     Conflicting COVID-19 excess mortality estimates.
     Lancet. 2023;401:431.
     PubMed    
     
     
     
261. O'NEILL D
     Conflicting COVID-19 excess mortality estimates.
     Lancet. 2023;401:431.
     PubMed    
     
     
     
262. SCHOLEY J, Karlinsky A, Kobak D, Tallack C, et al
     Conflicting COVID-19 excess mortality estimates.
     Lancet. 2023;401:431-432.
     PubMed    
     
     
     
263. PAN Y, Wang L, Feng Z, Xu H, et al
     Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis.
     Lancet. 2023 Feb 8:S0140-6736(23)00129-0. doi: 10.1016/S0140-6736(23)00129.
     PubMed     Abstract available
     
     
     
264. PREISER W, Maponga T
     So far, no novel SARS-CoV-2 variants from Beijing-and hopefully better scientific cooperation going forward.
     Lancet. 2023 Feb 8:S0140-6736(23)00268-4. doi: 10.1016/S0140-6736(23)00268.
     PubMed    
     
     
     
265. TAN H, Liu J, Zeng F
     China needs a scientific long COVID recovery-support platform.
     Lancet. 2023;401:344-345.
     PubMed    
     
     
     January 2023
266. MOHEBBI N, Ritter A, Wiegand A, Graf N, et al
     Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial.
     Lancet. 2023 Jan 25:S0140-6736(22)02606-X. doi: 10.1016/S0140-6736(22)02606.
     PubMed     Abstract available
     
     
     
267. ELNAIEM A, Mohamed-Ahmed O, Zumla A, Mecaskey J, et al
     Global and regional governance of One Health and implications for global health security.
     Lancet. 2023 Jan 19:S0140-6736(22)01597-5. doi: 10.1016/S0140-6736(22)01597.
     PubMed     Abstract available
     
     
     
268. TRAORE T, Shanks S, Haider N, Ahmed K, et al
     How prepared is the world? Identifying weaknesses in existing assessment frameworks for global health security through a One Health approach.
     Lancet. 2023 Jan 19:S0140-6736(22)01589-6. doi: 10.1016/S0140-6736(22)01589.
     PubMed     Abstract available
     
     
     
269. MWATONDO A, Rahman-Shepherd A, Hollmann L, Chiossi S, et al
     A global analysis of One Health Networks and the proliferation of One Health collaborations.
     Lancet. 2023 Jan 19:S0140-6736(22)01596-3. doi: 10.1016/S0140-6736(22)01596.
     PubMed     Abstract available
     
     
     
270. ELLINGTON S, Jatlaoui TC
     COVID-19 vaccination is effective at preventing severe illness and complications during pregnancy.
     Lancet. 2023 Jan 17:S0140-6736(22)02613-7. doi: 10.1016/S0140-6736(22)02613.
     PubMed    
     
     
     
271. VILLAR J, Soto Conti CP, Gunier RB, Ariff S, et al
     Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study.
     Lancet. 2023 Jan 17:S0140-6736(22)02467-9. doi: 10.1016/S0140-6736(22)02467.
     PubMed     Abstract available
     
     
     
272. THE LANCET
     The COVID-19 pandemic in 2023: far from over.
     Lancet. 2023;401:79.
     PubMed    
     
     
     
273. BAKER MG, Durrheim D, Hsu LY, Wilson N, et al
     COVID-19 and other pandemics require a coherent response strategy.
     Lancet. 2023 Jan 13:S0140-6736(22)02489-8. doi: 10.1016/S0140-6736(22)02489.
     PubMed    
     
     
     December 2022
274. TIBBLE H, Mueller T, Proud E, Hall E, et al
     Uptake of monoclonal antibodies and antiviral therapies for COVID-19 in Scotland.
     Lancet. 2022 Dec 22:S0140-6736(22)02398-4. doi: 10.1016/S0140-6736(22)02398.
     PubMed    
     
     
     
275. KIDD MR, Kelly PM
     PANORAMIC: important insights into molnupiravir use in COVID-19.
     Lancet. 2022 Dec 22:S0140-6736(22)02593-4. doi: 10.1016/S0140-6736(22)02593.
     PubMed    
     
     
     
276. BUTLER CC, Hobbs FDR, Gbinigie OA, Rahman NM, et al
     Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial.
     Lancet. 2022 Dec 22:S0140-6736(22)02597-1. doi: 10.1016/S0140-6736(22)02597.
     PubMed     Abstract available
     
     
     
277. SELVARAJAH S, Corona Maioli S, Deivanayagam TA, de Morais Sato P, et al
     Racism, xenophobia, and discrimination: mapping pathways to health outcomes.
     Lancet. 2022;400:2109-2124.
     PubMed     Abstract available
     
     
     
278. DEVAKUMAR D, Selvarajah S, Abubakar I, Kim SS, et al
     Racism, xenophobia, discrimination, and the determination of health.
     Lancet. 2022;400:2097-2108.
     PubMed     Abstract available
     
     
     
279. ELSON W, Zambon M, de Lusignan S
     Integrated respiratory surveillance after the COVID-19 pandemic.
     Lancet. 2022;400:1924-1925.
     PubMed    
     
     
     November 2022
280. THE LANCET EDITORS
     Expression of concern: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
     Lancet. 2022 Nov 24:S0140-6736(22)02370-4. doi: 10.1016/S0140-6736(22)02370.
     PubMed    
     
     
     
281. HORTON R
     Offline: COVID-19-the lessons that science forgot.
     Lancet. 2022;400:1753.
     PubMed    
     
     
     
282. 
     Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
     Lancet. 2022 Nov 18:S0140-6736(22)02185-7. doi: 10.1016/S0140-6736(22)02185.
     PubMed     Abstract available
     
     
     
283. GOSTIN LO, Friedman EA, Hossain S, Mukherjee J, et al
     Human rights and the COVID-19 pandemic: a retrospective and prospective analysis.
     Lancet. 2022 Nov 17:S0140-6736(22)01278-8. doi: 10.1016/S0140-6736(22)01278.
     PubMed     Abstract available
     
     
     
284. OWEN A, Diaz JV, Guyatt G, Lamontagne F, et al
     WHO Living Guidelines on antivirals for COVID-19 are evidence-based.
     Lancet. 2022 Nov 10. pii: S0140-6736(22)02306.
     PubMed    
     
     
     
285. KALRA PR, Cleland JGF, Petrie MC, Thomson EA, et al
     Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial.
     Lancet. 2022 Nov 4. pii: S0140-6736(22)02083.
     PubMed     Abstract available
     
     
     
286. DOWRICK A, Rai T, Hinton L, Eacott B, et al
     Health inequalities, ethnic minorities and COVID19: interactive theatre workshop drawing on a qualitative interview study.
     Lancet. 2022;400 Suppl 1:S9.
     PubMed     Abstract available
     
     
     
287. ZURIAGA A, Flannigan L, Wilson J, Weiss S, et al
     A partnership approach to supporting the health and wellbeing of the Charedi (Orthodox Jewish) community in London.
     Lancet. 2022;400 Suppl 1:S85.
     PubMed     Abstract available
     
     
     
288. PANTELIC M, Ziauddeen N, Boyes M, O'Hara ME, et al
     The prevalence of stigma in a UK community survey of people with lived experience of long COVID.
     Lancet. 2022;400 Suppl 1:S84.
     PubMed     Abstract available
     
     
     
289. TWEED S
     Experience of homelessness during the COVID-19 pandemic in Tower Hamlets, London: a health needs assessment.
     Lancet. 2022;400 Suppl 1:S82.
     PubMed     Abstract available
     
     
     
290. TURNER G, de'Donato F, Kovats S, Hoeben A, et al
     Implementation of adaptation to climate change in public health in Europe: qualitative thematic analysis.
     Lancet. 2022;400 Suppl 1:S81.
     PubMed     Abstract available
     
     
     
291. TORRESIN S, Ratcliffe E, Aletta F, Albatici R, et al
     The effect of indoor soundscape on sexual wellbeing during the COVID-19 lockdown in London: a thematic analysis of remote workers' experiences.
     Lancet. 2022;400 Suppl 1:S80.
     PubMed     Abstract available
     
     
     
292. SCOTT S, McGowan VJ, Wildman JM, Bidmead E, et al
     COVID-19 and the role of Voluntary, Community, and Social Enterprises in northern England in responding to the needs of marginalised communities: a qualitative focus group study.
     Lancet. 2022;400 Suppl 1:S78.
     PubMed     Abstract available
     
     
     
293. SERKA S, Mainwaring J
     Perspectives of education and mental health professionals on adolescent school-based mental health promotion: a qualitative exploration.
     Lancet. 2022;400 Suppl 1:S76.
     PubMed     Abstract available
     
     
     
294. ROSENTHAL DM, Heys M, Schoenthaler A, Hayward A, et al
     How did living in temporary accommodation during the COVID-19 pandemic affect children younger than 5 years' access to health care and health outcomes? A qualitative study of key professionals in a socially and ethnically diverse and deprived area of
     Lancet. 2022;400 Suppl 1:S75.
     PubMed     Abstract available
     
     
     
295. QI C, Osborne T, Bailey R, Hollinghurst J, et al
     Effect of the COVID-19 pandemic on incidence of long-term conditions in Welsh residents: a population linkage study.
     Lancet. 2022;400 Suppl 1:S69.
     PubMed     Abstract available
     
     
     
296. NIRANJAN V, Fitzpatrick P, Morrogh R, O'Hagan K, et al
     Evaluation of community outreach feasibility programmes on improving cancer-related, preventive, health behaviour.
     Lancet. 2022;400 Suppl 1:S67.
     PubMed     Abstract available
     
     
     
297. MCQUIRE C, Zuccolo L, Frennesson F, Butcher S, et al
     Prenatal alcohol prevention in the UK: mapping the landscape through systematic collaborative review.
     Lancet. 2022;400 Suppl 1:S64.
     PubMed     Abstract available
     
     
     
298. MCKINLAY AR, Collins L, Fancourt D, Burton A, et al
     How did female survivors of abuse use the arts to support their mental health and wellbeing during the COVID-19 pandemic? A qualitative exploration of their views.
     Lancet. 2022;400 Suppl 1:S63.
     PubMed     Abstract available
     
     
     
299. PARNHAM JC, Vamos EP, McKevitt S, Laverty AA, et al
     The UK's Free School Meals policy during the pandemic: a thematic content analysis of policy documents and debates.
     Lancet. 2022;400 Suppl 1:S62.
     PubMed     Abstract available
     
     
     
300. TINNER L
     Exploring young people's perceptions of health and inequality through art: a co-produced qualitative study.
     Lancet. 2022;400 Suppl 1:S6.
     PubMed     Abstract available
     
     
     
301. MAKANJUOLA A, Lynch M, Hartfiel N, Cuthbert A, et al
     Social return on investment of face-to-face versus online lifestyle coaching to improve mental wellbeing.
     Lancet. 2022;400 Suppl 1:S59.
     PubMed     Abstract available
     
     
     
302. KEEBLE M, Adams J, Burgoine T
     Changes in online food access during the COVID-19 pandemic and associations with deprivation: a longitudinal analysis.
     Lancet. 2022;400 Suppl 1:S54.
     PubMed     Abstract available
     
     
     
303. BURNS R, Campos-Matos I, Harron K, Aldridge RW, et al
     COVID-19 vaccination uptake for half a million non-EU migrants and refugees in England: a linked retrospective population-based cohort study.
     Lancet. 2022;400 Suppl 1:S5.
     PubMed     Abstract available
     
     
     
304. GRAY BJ, Kyle RG, Challenger A, Davies AR, et al
     Mental health of the nursing and midwifery workforce in Wales during the COVID-19 pandemic: a cross-sectional analysis.
     Lancet. 2022;400 Suppl 1:S43.
     PubMed     Abstract available
     
     
     
305. HUF SW, Woldmann L, Crespo RF, Grailey K, et al
     Implementing behavioural science informed letter interventions to increase COVID-19 vaccination uptake in uncontactable London residents: a difference-in-difference study in London, UK.
     Lancet. 2022;400 Suppl 1:S41.
     PubMed     Abstract available
     
     
     
306. GEISMAR C, Nguyen V, Fragaszy E, Shrotri M, et al
     Bayesian reconstruction of household transmissions to infer the serial interval of COVID-19 by variants of concern: analysis from a prospective community cohort study (Virus Watch).
     Lancet. 2022;400 Suppl 1:S40.
     PubMed     Abstract available
     
     
     
307. DAWES J, May T, Fancourt D, Burton A, et al
     The impact of the COVID-19 pandemic on people experiencing homelessness: a qualitative interview study in the UK.
     Lancet. 2022;400 Suppl 1:S35.
     PubMed     Abstract available
     
     
     
308. CURTIN EL, Widnall E, Dodd S, Limmer M, et al
     The Peer Education Project to improve mental health literacy in secondary school students in England: a qualitative realist evaluation.
     Lancet. 2022;400 Suppl 1:S34.
     PubMed     Abstract available
     
     
     
309. BRIGHT D, Song J, Hillier S, Huws DW, et al
     Impact of the temporary suspension of the Bowel Screening Wales programme on inequalities during the COVID-19 pandemic: a retrospective register-based study.
     Lancet. 2022;400 Suppl 1:S25.
     PubMed     Abstract available
     
     
     
310. BEYNON C
     Exploring the association between obesity and problems with peer relationships in children: a nationally representative cross-sectional study.
     Lancet. 2022;400 Suppl 1:S21.
     PubMed     Abstract available
     
     
     
311. BERNARD A, Salhi L, de Ossorno Garcia S, John A, et al
     Engagement of individuals aged 14-25 years with a digital mental health service during the COVID-19 pandemic in the UK: a cohort study of service usage data.
     Lancet. 2022;400 Suppl 1:S20.
     PubMed     Abstract available
     
     
     
312. ANDREAE G, Scott S, Nguyen G, Bell Z, et al
     Food insecurity among pregnant women living in high-income countries: a systematic review.
     Lancet. 2022;400 Suppl 1:S17.
     PubMed     Abstract available
     
     
     
313. GRIFFITHS ML, Gray BJ, Kyle RG, Davies AR, et al
     Shifting priorities and employment choices among workers in Wales during the COVID-19 pandemic: a longitudinal analysis.
     Lancet. 2022;400 Suppl 1:S1.
     PubMed     Abstract available
     
     
     October 2022
314. 
     Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries.
     Lancet. 2022 Oct 31. pii: S0140-6736(22)01846.
     PubMed     Abstract available
     
     
     
315. FRENK J, Chen LC, Chandran L, Groff EOH, et al
     Challenges and opportunities for educating health professionals after the COVID-19 pandemic.
     Lancet. 2022;400:1539-1556.
     PubMed     Abstract available
     
     
     
316. DAS M, Keke K
     Pandemic solidarity across national borders saved lives.
     Lancet. 2022;400:1510-1511.
     PubMed    
     
     
     
317. AGUS DB, Nguyen A, Sall AA, Bell J, et al
     COVID-19 and other adult vaccines can drive global disease prevention.
     Lancet. 2022 Oct 27. pii: S0140-6736(22)02084.
     PubMed    
     
     
     
318. OPEL DJ, Brewer NT, Buttenheim AM, Callaghan T, et al
     The legacy of the COVID-19 pandemic for childhood vaccination in the USA.
     Lancet. 2022 Oct 26. pii: S0140-6736(22)01693.
     PubMed    
     
     
     
319. LEFRANCOIS T, Malvy D, Atlani-Duault L, Benamouzig D, et al
     After 2 years of the COVID-19 pandemic, translating One Health into action is urgent.
     Lancet. 2022 Oct 21. pii: S0140-6736(22)01840.
     PubMed    
     
     
     
320. AGRAWAL U, Bedston S, McCowan C, Oke J, et al
     Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales.
     Lancet. 2022;400:1305-1320.
     PubMed     Abstract available
     
     
     
321. MSELLATI P, Sow K, Desclaux A, Cottrell G, et al
     Reconsidering the COVID-19 vaccine strategy in West and Central Africa.
     Lancet. 2022;400:1304.
     PubMed    
     
     
     
322. IRVING SA, Sundaram ME
     Prioritisation of COVID-19 boosters in the omicron era.
     Lancet. 2022;400:1282-1283.
     PubMed    
     
     
     
323. WONG CKH, Au ICH, Lau KTK, Lau EHY, et al
     Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kon
     Lancet. 2022;400:1213-1222.
     PubMed     Abstract available
     
     
     
324. BURDET C, Ader F
     Real-world effectiveness of oral antivirals for COVID-19.
     Lancet. 2022;400:1175-1176.
     PubMed    
     
     
     
325. FRENK J, Godal T, Gomez-Dantes O, Store JG, et al
     A reinvigorated multilateralism in health: lessons and innovations from the COVID-19 pandemic.
     Lancet. 2022 Oct 7. pii: S0140-6736(22)01943.
     PubMed    
     
     
     
326. WU MY, Carr EJ, Harvey R, Mears HV, et al
     WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed.
     Lancet. 2022 Oct 6. pii: S0140-6736(22)01938.
     PubMed    
     
     
     September 2022
327. HAMEED SS, Hall E, Grange Z, Sullivan C, et al
     Characterising adults in Scotland who are not vaccinated against COVID-19.
     Lancet. 2022;400:993-995.
     PubMed    
     
     
     
328. THE LANCET
     COVID-19: the case for prosociality.
     Lancet. 2022 Sep 14. pii: S0140-6736(22)01761.
     PubMed    
     
     
     
329. SACHS JD, Karim SSA, Aknin L, Allen J, et al
     The Lancet Commission on lessons for the future from the COVID-19 pandemic.
     Lancet. 2022 Sep 14. pii: S0140-6736(22)01585.
     PubMed    
     
     
     
330. YEK C, Warner S, Mancera A, Kadri SS, et al
     Misclassification bias in estimating clinical severity of SARS-CoV-2 variants.
     Lancet. 2022;400:809.
     PubMed    
     
     
     
331. NYBERG T, Ferguson NM, Blake J, Hinsley W, et al
     Misclassification bias in estimating clinical severity of SARS-CoV-2 variants - Authors' reply.
     Lancet. 2022;400:809-810.
     PubMed    
     
     
     
332. ZHANG Y, Wang Y, Ning G, He P, et al
     Protecting older people: a high priority during the COVID-19 pandemic.
     Lancet. 2022;400:729-730.
     PubMed    
     
     
     
333. THORNTON J
     New centre for pandemic therapeutics.
     Lancet. 2022;400:722.
     PubMed    
     
     
     
334. GORMAN EA, O'Kane CM, McAuley DF
     Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management.
     Lancet. 2022 Sep 2. pii: S0140-6736(22)01439.
     PubMed     Abstract available
     
     
     August 2022
335. UYEKI TM, Hui DS, Zambon M, Wentworth DE, et al
     Influenza.
     Lancet. 2022;400:693-706.
     PubMed     Abstract available
     
     
     
336. BOLLYKY TJ, Angelino O, Wigley S, Dieleman JL, et al
     Trust made the difference for democracies in COVID-19.
     Lancet. 2022;400:657.
     PubMed    
     
     
     
337. MOETI M, Gao GF, Herrman H
     Global pandemic perspectives: public health, mental health, and lessons for the future.
     Lancet. 2022;400:e3-e7.
     PubMed    
     
     
     
338. 
     The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019.
     Lancet. 2022;400:563-591.
     PubMed     Abstract available
     
     
     
339. HILL M, Bandyopadhyay AS, Pollard AJ
     Emergence of vaccine-derived poliovirus in high-income settings in the absence of oral polio vaccine use.
     Lancet. 2022 Aug 18. pii: S0140-6736(22)01582.
     PubMed    
     
     
     
340. BALLERING AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, et al
     Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study.
     Lancet. 2022;400:452-461.
     PubMed     Abstract available
     
     
     
341. SORENSEN RJD
     COVID-19 and microbiome diversity in sub-Saharan Africa - Author's reply.
     Lancet. 2022;400:429-430.
     PubMed    
     
     
     
342. VAN DAMME W, Wamai R, Assefa Y, Liesenborghs L, et al
     COVID-19 and microbiome diversity in sub-Saharan Africa.
     Lancet. 2022;400:429.
     PubMed    
     
     
     
343. BRIGHTLING CE, Evans RA
     Long COVID: which symptoms can be attributed to SARS-CoV-2 infection?
     Lancet. 2022;400:411-413.
     PubMed    
     
     
     July 2022
344. 
     Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
     Lancet. 2022;400:359-368.
     PubMed     Abstract available
     
     
     
345. THORNTON J
     Violence against health workers rises during COVID-19.
     Lancet. 2022;400:348.
     PubMed    
     
     
     
346. MEHTA P, Titanji BK
     Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality.
     Lancet. 2022;400:338-339.
     PubMed    
     
     
     
347. LAWTON T, Alwan NA
     The UK COVID-19 Inquiry must examine the foundations of pandemic decision making.
     Lancet. 2022 Jul 18. pii: S0140-6736(22)01332.
     PubMed    
     
     
     
348. 
     Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020.
     Lancet. 2022;400:185-235.
     PubMed     Abstract available
     
     
     
349. MESSACAR K, Baker RE, Park SW, Nguyen-Tran H, et al
     Preparing for uncertainty: endemic paediatric viral illnesses after COVID-19 pandemic disruption.
     Lancet. 2022 Jul 14. pii: S0140-6736(22)01277.
     PubMed    
     
     
     
350. DURRHEIM DN
     Perilous two-tier COVID-19 global vaccine roll-out.
     Lancet. 2022 Jul 11. pii: S0140-6736(22)01284.
     PubMed    
     
     
     
351. WOLTER N, Jassat W, von Gottberg A, Cohen C, et al
     Clinical severity of omicron lineage BA.2 infection compared with BA.1 infection in South Africa.
     Lancet. 2022;400:93-96.
     PubMed    
     
     
     
352. MELLO MM, Opel DJ, Benjamin RM, Callaghan T, et al
     Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA.
     Lancet. 2022 Jul 8. pii: S0140-6736(22)00875.
     PubMed    
     
     
     
353. GOGA A, Bekker LG, Garrett N, Reddy T, et al
     Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa.
     Lancet. 2022 Jul 6. pii: S0140-6736(22)01190.
     PubMed    
     
     
     
354. NASSIRI-ANSARI T, Atuhebwe P, Ayisi AS, Goulding S, et al
     Shifting gender barriers in immunisation in the COVID-19 pandemic response and beyond.
     Lancet. 2022;400:24.
     PubMed    
     
     
     
355. PFAFF F, Hoffmann D, Beer M
     Monkeypox genomic surveillance will challenge lessons learned from SARS-CoV-2.
     Lancet. 2022;400:22-23.
     PubMed    
     
     
     June 2022
356. SACCO C, Del Manso M, Mateo-Urdiales A, Rota MC, et al
     Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022.
     Lancet. 2022 Jun 30. pii: S0140-6736(22)01185.
     PubMed     Abstract available
     
     
     
357. LADHANI SN
     COVID-19 vaccination for children aged 5-11 years.
     Lancet. 2022 Jun 30. pii: S0140-6736(22)01245.
     PubMed    
     
     
     
358. BURKI T
     COVID-19 in North Korea.
     Lancet. 2022;399:2339.
     PubMed    
     
     
     
359. ANTONELLI M, Pujol JC, Spector TD, Ourselin S, et al
     Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2.
     Lancet. 2022;399:2263-2264.
     PubMed    
     
     
     
360. OFRI D
     Memorialising COVID-19.
     Lancet. 2022;399:2260-2261.
     PubMed    
     
     
     
361. LI G, Cappuccini F, Marchevsky NG, Aley PK, et al
     Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.
     Lancet. 2022;399:2212-2225.
     PubMed     Abstract available
     
     
     
362. WONG HL, Hu M, Zhou CK, Lloyd PC, et al
     Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases.
     Lancet. 2022;399:2191-2199.
     PubMed     Abstract available
     
     
     
363. PATEL M, Patel M
     Increasing children's global access to COVID-19 vaccines.
     Lancet. 2022;399:2171-2173.
     PubMed    
     
     
     
364. HUSBY A, Kober L
     COVID-19 mRNA vaccination and myocarditis or pericarditis.
     Lancet. 2022;399:2168-2169.
     PubMed    
     
     
     May 2022
365. CLARK H, Cardenas M, Dybul M, Kazatchkine M, et al
     Transforming or tinkering: the world remains unprepared for the next pandemic threat.
     Lancet. 2022;399:1995-1999.
     PubMed    
     
     
     
366. NELLUMS LB, Latif A, Nkhoma K, Timmons S, et al
     COVID-19 boosters and building trust among UK minority ethnic communities.
     Lancet. 2022 May 25. pii: S0140-6736(22)00945.
     PubMed    
     
     
     
367. DENNEHY JJ, Gupta RK, Hanage WP, Johnson MC, et al
     Where is the next SARS-CoV-2 variant of concern?
     Lancet. 2022;399:1938-1939.
     PubMed    
     
     
     
368. KICKBUSCH I, Liu A
     Global health diplomacy-reconstructing power and governance.
     Lancet. 2022 May 17. pii: S0140-6736(22)00583.
     PubMed     Abstract available
     
     
     
369. YUAN S
     Zero COVID in China: what next?
     Lancet. 2022;399:1856-1857.
     PubMed    
     
     
     
370. SHERLOCK PL
     COVID-19 and inter-generational solidarity.
     Lancet. 2022;399:1775.
     PubMed    
     
     
     
371. THE LANCET
     COVID-19: the next phase and beyond.
     Lancet. 2022;399:1753.
     PubMed    
     
     
     
372. BHUTTA ZA, Boerma T, Black MM, Victora CG, et al
     Optimising child and adolescent health and development in the post-pandemic world.
     Lancet. 2022;399:1759-1761.
     PubMed    
     
     
     
373. JHA P, Brown PE, Ansumana R
     Counting the global COVID-19 dead.
     Lancet. 2022 May 6. pii: S0140-6736(22)00845.
     PubMed    
     
     
     
374. ZHANG X, Zhang W, Chen S
     Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic.
     Lancet. 2022 May 6. pii: S0140-6736(22)00838.
     PubMed    
     
     
     
375. CHRISTENSON SA, Smith BM, Bafadhel M, Putcha N, et al
     Chronic obstructive pulmonary disease.
     Lancet. 2022 May 6. pii: S0140-6736(22)00470.
     PubMed     Abstract available
     
     
     
376. DZAU VJ, Balatbat CA, Offodile AC 2nd
     Closing the global vaccine equity gap: equitably distributed manufacturing.
     Lancet. 2022 May 6. pii: S0140-6736(22)00793.
     PubMed    
     
     
     
377. 
     Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.
     Lancet. 2022 May 2. pii: S0140-6736(22)00519.
     PubMed     Abstract available
     
     
     April 2022
378. ADEPOJU P
     Africa CDC warns COVID-19 vaccine production could cease.
     Lancet. 2022;399:1683.
     PubMed    
     
     
     
379. VICTORA CG, Hartwig FP, Vidaletti LP, Martorell R, et al
     Effects of early-life poverty on health and human capital in children and adolescents: analyses of national surveys and birth cohort studies in LMICs.
     Lancet. 2022;399:1741-1752.
     PubMed     Abstract available
     
     
     
380. ARCHARD D, Buyx A, Delfraissy JF
     Responding to the humanitarian crisis of the war in Ukraine with lessons from COVID-19.
     Lancet. 2022 Apr 25. pii: S0140-6736(22)00731.
     PubMed    
     
     
     
381. GRAMMATOPOULOS DK, Young L, Anderson NR
     Transforming the UK's diagnostics agenda after COVID-19.
     Lancet. 2022;399:1606.
     PubMed    
     
     
     
382. JEFFORD M, Howell D, Li Q, Lisy K, et al
     Improved models of care for cancer survivors.
     Lancet. 2022;399:1551-1560.
     PubMed     Abstract available
     
     
     
383. FISHER D, Suri S, Carson G
     What comes next in the COVID-19 pandemic?
     Lancet. 2022 Apr 11. pii: S0140-6736(22)00580.
     PubMed    
     
     
     
384. BUCHBINDER SP, McElrath MJ, Dieffenbach C, Corey L, et al
     COVID-19 vaccination and HIV-1 acquisition - Authors' reply.
     Lancet. 2022;399:e36.
     PubMed    
     
     
     
385. LOGUNOV DY, Livermore DM, Ornelles DA, Bayer W, et al
     COVID-19 vaccination and HIV-1 acquisition.
     Lancet. 2022;399:e34-e35.
     PubMed    
     
     
     
386. DWEK RA, Bell JI, Feldmann M, Zitzmann N, et al
     Host-targeting oral antiviral drugs to prevent pandemics.
     Lancet. 2022;399:1381-1382.
     PubMed    
     
     
     
387. 
     Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
     Lancet. 2022 Apr 8. pii: S0140-6736(22)00484.
     PubMed     Abstract available
     
     
     
388. SHIODA K, Lopman B
     How to interpret the total number of SARS-CoV-2 infections.
     Lancet. 2022 Apr 8. pii: S0140-6736(22)00629.
     PubMed    
     
     
     
389. MENNI C, Valdes AM, Polidori L, Antonelli M, et al
     Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.
     Lancet. 2022 Apr 7. pii: S0140-6736(22)00327.
     PubMed     Abstract available
     
     
     
390. HAN X, Li J, Chen Y, Li Y, et al
     SARS-CoV-2 nucleic acid testing is China's key pillar of COVID-19 containment.
     Lancet. 2022 Apr 7. pii: S0140-6736(22)00577.
     PubMed    
     
     
     
391. BERGMARK BA, Mathenge N, Merlini PA, Lawrence-Wright MB, et al
     Acute coronary syndromes.
     Lancet. 2022;399:1347-1358.
     PubMed     Abstract available
     
     
     
392. KHOBRAGADE A, Bhate S, Ramaiah V, Deshpande S, et al
     Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India.
     Lancet. 2022;399:1313-1321.
     PubMed     Abstract available
     
     
     
393. ZAROCOSTAS J
     Mixed response to COVID-19 intellectual property waiver.
     Lancet. 2022;399:1292-1293.
     PubMed    
     
     
     
394. BLAKNEY AK, Bekker LG
     DNA vaccines join the fight against COVID-19.
     Lancet. 2022;399:1281-1282.
     PubMed    
     
     
     
395. POST LA, Lorenzo-Redondo R
     Omicron: fewer adverse outcomes come with new dangers.
     Lancet. 2022;399:1280-1281.
     PubMed    
     
     
     March 2022
396. LUKE JJ, Rutkowski P, Queirolo P, Del Vecchio M, et al
     Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial.
     Lancet. 2022 Mar 31. pii: S0140-6736(22)00562.
     PubMed     Abstract available
     
     
     
397. 
     NCD Countdown 2030: efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low-income and middle-income countries.
     Lancet. 2022;399:1266-1278.
     PubMed     Abstract available
     
     
     
398. KRAUSE PR, Rees H, Figueroa JP, Swaminathan S, et al
     Booster vaccines for COVID-19 vaccine breakthrough cases? - Authors' reply.
     Lancet. 2022;399:1225.
     PubMed    
     
     
     
399. NIXON DF, Schwartz RE, Ndhlovu LC
     Booster vaccines for COVID-19 vaccine breakthrough cases?
     Lancet. 2022;399:1224.
     PubMed    
     
     
     
400. SWETS MC, Russell CD, Harrison EM, Docherty AB, et al
     SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses.
     Lancet. 2022 Mar 25. pii: S0140-6736(22)00383.
     PubMed    
     
     
     
401. KOLA L, Kumar M, Kohrt BA, Fatodun T, et al
     Strengthening public mental health during and after the acute phase of the COVID-19 pandemic.
     Lancet. 2022 Mar 24. pii: S0140-6736(22)00523.
     PubMed    
     
     
     
402. WATERS L, Marra F, Pozniak A, Cockburn J, et al
     Ritonavir and COVID-19: pragmatic guidance is important.
     Lancet. 2022 Mar 22. pii: S0140-6736(22)00280.
     PubMed    
     
     
     
403. BEKKER LG, Garrett N, Goga A, Fairall L, et al
     Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.
     Lancet. 2022;399:1141-1153.
     PubMed     Abstract available
     
     
     
404. PREISER W, Fish T
     Sisonke: reaching several goals together.
     Lancet. 2022;399:1095-1097.
     PubMed    
     
     
     
405. NYBERG T, Ferguson NM, Nash SG, Webster HH, et al
     Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
     Lancet. 2022 Mar 16. pii: S0140-6736(22)00462.
     PubMed     Abstract available
     
     
     
406. REARTE A, Castelli JM, Rearte R, Fuentes N, et al
     Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study.
     Lancet. 2022 Mar 15. pii: S0140-6736(22)00011.
     PubMed     Abstract available
     
     
     
407. MILLS EJ, Reis G
     Evaluating COVID-19 vaccines in the real world.
     Lancet. 2022 Mar 15. pii: S0140-6736(22)00194.
     PubMed    
     
     
     
408. YEN HL, Sit THC, Brackman CJ, Chuk SSY, et al
     Transmission of SARS-CoV-2 delta variant (AY.127) from pet hamsters to humans, leading to onward human-to-human transmission: a case study.
     Lancet. 2022;399:1070-1078.
     PubMed     Abstract available
     
     
     
409. HAAGMANS BL, Koopmans MPG
     Spreading of SARS-CoV-2 from hamsters to humans.
     Lancet. 2022;399:1027-1028.
     PubMed    
     
     
     
410. KHAN W, Abubakar A, Brennan RJ, Al Hosani F, et al
     Preparing for future pandemics in the Eastern Mediterranean region.
     Lancet. 2022;399:1032-1033.
     PubMed    
     
     
     
411. ABUBAKAR I, Dalglish SL, Angell B, Sanuade O, et al
     The Lancet Nigeria Commission: investing in health and the future of the nation.
     Lancet. 2022 Mar 11. pii: S0140-6736(21)02488.
     PubMed    
     
     
     
412. ANGELL B, Sanuade O, Adetifa IMO, Okeke IN, et al
     Population health outcomes in Nigeria compared with other west African countries, 1998-2019: a systematic analysis for the Global Burden of Disease Study.
     Lancet. 2022 Mar 11. pii: S0140-6736(21)02722.
     PubMed     Abstract available
     
     
     
413. 
     Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.
     Lancet. 2022 Mar 10. pii: S0140-6736(21)02796.
     PubMed     Abstract available
     
     
     
414. MANCA T, Baylis F, Munoz FM, Top KA, et al
     Prioritise research on vaccines for pregnant and breastfeeding women.
     Lancet. 2022;399:890-893.
     PubMed    
     
     
     
415. FALLAH MP, Reinhart E
     Apartheid logic in global health.
     Lancet. 2022;399:902-903.
     PubMed    
     
     
     
416. CORREIA LCL, Sette C, Santos M, Magliano CAS, et al
     Brazil's COVID-19 guidelines: political hijack of public health.
     Lancet. 2022 Mar 3. pii: S0140-6736(22)00338.
     PubMed    
     
     
     
417. KUCHARSKI AJ, Jit M, Logan JG, Cotten M, et al
     Travel measures in the SARS-CoV-2 variant era need clear objectives.
     Lancet. 2022 Mar 2. pii: S0140-6736(22)00366.
     PubMed    
     
     
     
418. FLOR LS, Friedman J, Spencer CN, Cagney J, et al
     Quantifying the effects of the COVID-19 pandemic on gender equality on health, social, and economic indicators: a comprehensive review of data from March, 2020, to September, 2021.
     Lancet. 2022 Mar 2. pii: S0140-6736(22)00008.
     PubMed     Abstract available
     
     
     
419. MORGAN R, Pimenta DN, Rashid S
     Gender equality and COVID-19: act now before it is too late.
     Lancet. 2022 Mar 2. pii: S0140-6736(22)00278.
     PubMed    
     
     
     February 2022
420. USHER AD
     The global COVID-19 treatment divide.
     Lancet. 2022;399:779-782.
     PubMed    
     
     
     
421. CHEMAITELLY H, Abu-Raddad LJ
     Waning effectiveness of COVID-19 vaccines.
     Lancet. 2022;399:771-773.
     PubMed    
     
     
     
422. THE LANCET
     Our commitment to help accelerate progress against cancer.
     Lancet. 2022;399:769.
     PubMed    
     
     
     
423. 
     Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis.
     Lancet. 2022 Feb 24. pii: S0140-6736(21)02867.
     PubMed     Abstract available
     
     
     
424. GU X, Cao B
     Understanding of COVID-19 from infection-fatality ratio.
     Lancet. 2022 Feb 24. pii: S0140-6736(22)00281.
     PubMed    
     
     
     
425. BAJAJ SS, Maki L, Stanford FC
     Vaccine apartheid: global cooperation and equity.
     Lancet. 2022 Feb 23. pii: S0140-6736(22)00328.
     PubMed    
     
     
     
426. ADAMS LV, Dorough DS
     Accelerating Indigenous health and wellbeing: the Lancet Commission on Arctic and Northern Health.
     Lancet. 2022;399:613-614.
     PubMed    
     
     
     
427. BURKI T
     Fresh questions over Gates Foundation governance.
     Lancet. 2022;399:508.
     PubMed    
     
     
     
428. HUMPHREYS K, Shover CL, Andrews CM, Bohnert ASB, et al
     Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.
     Lancet. 2022;399:555-604.
     PubMed    
     
     
     
429. THE LANCET
     Managing the opioid crisis in North America and beyond.
     Lancet. 2022;399:495.
     PubMed    
     
     
     
430. BEYRER C
     Archbishop Desmond Tutu and the universality of health and human rights.
     Lancet. 2022;399:503-504.
     PubMed    
     
     
     January 2022
431. WU M, Wall EC, Carr EJ, Harvey R, et al
     Three-dose vaccination elicits neutralising antibodies against omicron.
     Lancet. 2022 Jan 19. pii: S0140-6736(22)00092.
     PubMed    
     
     
     
432. LAXMINARAYAN R
     The overlooked pandemic of antimicrobial resistance.
     Lancet. 2022 Jan 18. pii: S0140-6736(22)00087.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum